Antitrust scrutiny of large technology companies may be in the headlines, but what some have dubbed “Big Med” is being eyed by the Biden Administration and federal agencies for heightened antitrust enforcement, according to attorneys for Davis, Wright Tremaine writing for JD Supra.
Hospitals, physician groups, and health plans already accustomed to an active antitrust enforcement climate may need to prepare for even choppier regulatory waters ahead as a new president and new leadership at the Federal Trade Commission and Department of Justice turn their focus on healthcare provider markets. Read more.
